# TherapeuticsMD, Inc.: Form 8-K, filed Apr 25, 2019

- Company: [TherapeuticsMD, Inc.](/companies/txmd.md) (CIK 25743)
- Form: 8-K
- Filed: 2019-04-25
- Accepted by EDGAR: Apr 25, 2019, 16:33 ET
- Period: 2019-04-24
- Accession: 0001387131-19-002928
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/25743/000138713119002928/txmd-8k_042419.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/25743/000138713119002928/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 2.04: Item not in the standard list
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/25743/000138713119002928/txmd-8k_042419.htm

Filed Apr 25, 2019.
Source: SEC EDGAR, the filing index for accession 0001387131-19-002928. Last ingested by Listed: Nov 14, 2026, 19:24 ET. No prices; not investment advice.
